Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:SNN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeSNNSmith & Nephew SNATS$30.51-0.8%$31.91$28.33▼$38.79$13.04B0.571.35 million shs1.04 million shsDon't wait for the SpaceX IPOThe space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceSNNSmith & Nephew SNATS0.00%+3.22%-4.53%-15.50%+6.29%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeSNNSmith & Nephew SNATS$30.51-0.8%$31.91$28.33▼$38.79$13.04B0.571.35 million shs1.04 million shsDon't wait for the SpaceX IPOThe space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceSNNSmith & Nephew SNATS0.00%+3.22%-4.53%-15.50%+6.29%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceSNNSmith & Nephew SNATS 2.40Hold$30.931.38% UpsideCurrent Analyst Ratings BreakdownLatest PCGH, SSON, SNN, and HGT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/11/2026SNNSmith & Nephew SNATS Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$31.855/11/2026SNNSmith & Nephew SNATS Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$32.00 ➝ $30.004/24/2026SNNSmith & Nephew SNATS Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$32.004/20/2026SNNSmith & Nephew SNATS Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)3/5/2026SNNSmith & Nephew SNATS Canaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$34.00 ➝ $35.00(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookSNNSmith & Nephew SNATS$6.16B2.11$3.43 per share8.90$12.45 per share2.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateSNNSmith & Nephew SNATS$625MN/AN/A12.151.00N/AN/AN/A8/4/2026 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthSNNSmith & Nephew SNATS$0.933.05%N/AN/AN/ALatest PCGH, SSON, SNN, and HGT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date3/5/2026SNNSmith & Nephew SNATS$0.48203.04%3/27/20263/27/20265/27/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioSNNSmith & Nephew SNATS0.602.571.25Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipSNNSmith & Nephew SNATS25.64%Insider OwnershipCompanyInsider OwnershipSNNSmith & Nephew SNATS1.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableSNNSmith & Nephew SNATS16,988426.99 million422.72 millionOptionablePCGH, SSON, SNN, and HGT HeadlinesRecent News About These CompaniesSmith & Nephew SNATS, Inc. (NYSE:SNN) Given Consensus Recommendation of "Hold" by BrokeragesMay 20, 2026 | americanbankingnews.comVEEV Boosts MedTech Quality Management With Smith+Nephew PartnershipMay 13, 2026 | zacks.comSmith & Nephew SNATS (NYSE:SNN) Stock Rating Lowered by Wall Street ZenMay 9, 2026 | marketbeat.comSmith & Nephew plc (SNN) Q1 2026 Sales/Trading Call TranscriptMay 6, 2026 | seekingalpha.comSmith+Nephew initiates $500M share buyback with Q1 sales beatMay 6, 2026 | massdevice.comSmith & Nephew plc (SNN) Q1 2026 Sales/ Trading Statement Call - SlideshowMay 6, 2026 | seekingalpha.comUK's Smith+Nephew keeps annual outlook, plans share buyback as quarterly revenue risesMay 6, 2026 | reuters.comSmith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026May 5, 2026 | globenewswire.comSNN vs. BSX: Which Stock Is the Better Value Option?May 5, 2026 | zacks.comCanaccord Cuts PT on Smith & Nephew (SNN) Ahead of Fiscal Q1 ResultsMay 1, 2026 | insidermonkey.comTeachers Retirement System of The State of Kentucky Purchases 144,800 Shares of Smith & Nephew SNATS, Inc. $SNNApril 26, 2026 | marketbeat.comSmith & Nephew SNATS, Inc. (NYSE:SNN) Receives Consensus Recommendation of "Hold" from BrokeragesApril 25, 2026 | marketbeat.comSNN's CARTIHEAL Cartilage Implant Beats Standard Care in 5-Year StudyApril 24, 2026 | zacks.comSNN Launches ALLEVYN COMPLETE CARE Dressing for Wound ManagementMarch 11, 2026 | zacks.comSmith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury preventionMarch 10, 2026 | globenewswire.comSmith & Nephew Posts Strong 2025 Results and Unveils Next-Phase Growth StrategyMarch 6, 2026 | theglobeandmail.comSmith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026March 3, 2026 | globenewswire.comSmith & Nephew plc (NYSE:SNN) Q4 2025 Earnings Call TranscriptMarch 3, 2026 | insidermonkey.comSmith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026March 2, 2026 | globenewswire.comSmith & Nephew plc 2025 Q4 - Results - Earnings Call PresentationMarch 2, 2026 | seekingalpha.comSmith & Nephew posts sharp rise in profit and cash flowMarch 2, 2026 | proactiveinvestors.co.ukNew MarketBeat Followers Over TimeMedia Sentiment Over TimePCGH, SSON, SNN, and HGT Company DescriptionsSmith & Nephew SNATS NYSE:SNN$30.50 -0.26 (-0.83%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$30.54 +0.03 (+0.10%) As of 05/22/2026 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Palantir and Dell Build an AI OS for the Paranoid Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
